Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Double-Blinded, Vehicle- and Placebo-Controlled, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of IDCT in Subjects With Single-Level, Symptomatic Lumbar Intervertebral Disc Degeneration
Conditions
Interventions
IDCT
Saline Solution
+1 more
Locations
14
United States
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
University of Southern California
Los Angeles, California, United States
UC San Diego CIRM Alpha Stem Cell Clinic
San Diego, California, United States
Source Healthcare
Santa Monica, California, United States
Otrimed
Edgewood, Kentucky, United States
Spine Institute of Louisiana
Shreveport, Louisiana, United States
Start Date
February 26, 2018
Primary Completion Date
February 1, 2022
Completion Date
November 10, 2022
Last Updated
January 25, 2023
NCT07127380
NCT07254806
NCT05508360
NCT05037968
NCT05029726
NCT06011551
Lead Sponsor
DiscGenics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions